Indore: State health authorities directed all chief medical and health officers (CMHOs) for sending samples of all batches of an iron chelator drug (defrasirox tablets) to state drug lab for testing following complaints of side-effects. In a letter, chief general manager (Technical), Madhya Pradesh Public Health Services Corporation Limited (MPPHSCL) wrote that complaints of side-effects (vomiting, nausea, diarrhoea) were reported among children following consumption of deferasirox dispersible tablet (100 mg, 500 mg).All CMHOs have been directed to send samples of all batches of medicine supplied by a private company, if available in the stores to the state drug laboratory, stated MPPHSCL official in the letter. TOI is in possession of the orders copy.The drug is prescribed to reduce excessive iron in patients undergoing frequent, long term blood transfusions for conditions like thalassemia and other chronic anaemia. Commissioner, department of Health and family welfare Dr Sudam Khade refrained from replying to this issue and said, You shall talk with corporation managing director Pankaj Jain. MD, MPPHSCL, Pankaj Jain said, I am in Rajasthan for election duty for the last 15 days and would remain here for two more weeks. I am not in charge of the corporation so it wouldnt be appropriate for me to comment on this issue. The corporation is the agency that centrally supplies drugs, and equipment to all government health facilities in Madhya Pradesh. We also published the following articles recentlySide effects of taking too many vitaminsOverconsumption of vitamins can have adverse side effects, including nausea, stomach cramps, and diarrhea. Some vitamins, like A and D, can cause more severe symptoms such as dizziness, hair loss, and liver damage. Excessive intake of vitamins B6, B3, and iron can lead to nerve damage, liver problems, and organ damage, respectively. It is important to follow recommended daily allowances and consult with a healthcare professional before starting any supplement regimen to avoid overdosing and ensure good health.Pakistan: Warning issued against batch of widely-consumed syrup; recall initiated due to potential health risksPakistans Drug Regulatory Authority (DRAP) has issued a warning about batch L-083 of Weena Syrup, produced by Ms Swat Pharmaceuticals, due to potential health risks. The syrup is commonly used for treating iron deficiency anemia. The defective batch can cause gastrointestinal distress symptoms. The manufacturer has been instructed to recall the batch, pharmacies have been told to stop supplying it, and remaining stock must be returned. This comes after a ban was imposed on five cough syrups in Punjab due to excessive alcohol content. The government plans to crackdown on all medical stores distributing these syrups.Cancer packages most availed of under states health schemeThe state government of Maharashtra in India has approved the inclusion of advanced molecular and radiological diagnostic tests in its healthcare scheme for cancer patients. Previously, the scheme primarily focused on supporting core treatments such as surgery and radiotherapy, with limited coverage for pre- and post-operative tests. The inclusion of these advanced tests, such as genetic tests and liquid biopsies, is seen as a significant development that could save lives. However, certain expensive versions of liquid biopsy tests were not included due to their high cost.

Stay updated with all the Latest Indore headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.